OOIR: Observatory of International Research

Papers

(The TQCC of Addiction Science & Clinical Practice is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Examining outcomes for service users accessing the Breaking Free Online computer-assisted therapy program for substance use disorders via a ‘telehealth’ approach: protocol for a two arm, parallel grou	77
Is it about substituting an addiction with another? development and initial psychometric properties of the first heated tobacco products addiction questionnaire (HeaTPAQ)	59
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series	51
Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals	44
Patient perceptions of the use of e-cigarettes in smoking treatment programs: a qualitative analysis	37
Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use	30
Improving alcohol and substance use screening in school-age children: translation, adaptation and psychometric evaluation of the CRAFFT tool for Lumasaaba, Uganda	30
Virtual reality cue exposure as an add-on to smoking cessation group therapy: a randomized controlled trial	27
Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial	26
Problematic substance use among patients in a Swedish outpatient psychiatry setting: staff and manager perceptions of digital options for increased intervention access	25
Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process	24
Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study	23
Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study	19
Correction: Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population	18
A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting	18
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use	18
Virtual reality interventions in the assessment and treatment of alcohol use disorder - a systematic scoping review on methodology	18
Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial	17
Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study	17
Patient evaluation of a smartphone application for telehealth care of opioid use disorder	16
Spatial accessibility of substance use disorder treatment programs, compared with other health care facilities, in New York State, 2024	16
The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State	16
Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder	15
Correction: Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis	15
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with metham	14

What smartphone apps exist to support recovery from opioid use disorder? A content analysis of publicly available opioid-related smartphone apps	14
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation	13
Proceedings of the 18th Annual Conference of INEBRIA	13
Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods	13
“Take services to the people”: strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda	13
Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis	12
Patient centered medication treatment for opioid use disorder in rural Vermont: a qualitative study	12
“There’s always somebody that you can identify with”: a qualitative study of patient perspectives on buprenorphine group medical visits	12
Methadone clinic staff perceptions of trauma-informed and patient-centered care: the role of individual staff characteristics	12
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder	11
Integrating substance use peer support and screening brief intervention and referral to treatment services in the emergency department: a descriptive study of the ED leads program	11
A stakeholder-driven approach to designing a peer recovery coach role for implementation in community-oriented primary care teams in South Africa	10
“It beats the hell out of going to a hospital”: service user experiences of telemedicine-based symptom-triggered alcohol withdrawal management	10
Healthcare staff’s perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study	10
Substance use disorder bridge clinics: models, evidence, and future directions	10
A systematic review of substance use screening in outpatient behavioral health settings	10
Preliminary feasibility of integrating tobacco treatment into SUD peer recovery coaching: a mixed-methods study of peer recovery coaches	10
An investigation of fentanyl and methamphetamine use among first-time arrestees from 25 county jails across the U.S. in 2023	10
Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol	9
Patient experiences of buprenorphine dispensing from a mobile medical unit	9
Chronic unilateral groin pain in a young patient who injects drugs: a case report of needle fragment retentions	9
The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis	9
Patient characteristics associated with their level of twelve-step attendance prior to entry into treatment for substance use disorders	9
The development and initial validation of the Russian version of the BASIS-24	9
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants	9
Automated Reinforcement Management System (ARMS): focused phase I provider feedback	9
Rethinking trazodone for insomnia in alcohol use disorder	8
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule	8
Comparison of heroin and fentanyl use in US nationally representative surveys	8
Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018	8
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey	8
Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries	8
Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky	7
The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care	7
Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology	7
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative	7
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use d	7
Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial	7
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder	7
Effectiveness and feasibility of a motivational interviewing intake (MII) intervention for increasing client engagement in outpatient addiction treatment: an effectiveness-implementation hybrid design	7
Subtypes and service utilization among opioid use disorder patients at a community health center: findings from a medically underserved urban area of the Northeastern United States	7
Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods	7
Using mixed methods to establish tobacco treatment acceptability from the perspective of clients and clinicians of antenatal substance use services	7
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder	7
Attitudes and training related to substance use in pediatric emergency departments	7
CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool—a protocol paper	6
Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders	6
Improving alcohol health literacy and reducing alcohol consumption: recommendations for Germany	6
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review	6
Rapid intravenous symptom-inhibiting fentanyl induction (SIFI) to optimize rotation onto oral opioid agonist therapy among individuals who use unregulated fentanyl: protocol for an open-label, single	6

Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 rec	6
The measurement-based care to opioid treatment programs project (MBC2OTP): a study protocol using rapid assessment procedure informed clinical ethnography	6
Training health professionals to reduce overreporting of birthing people who use drugs to child welfare	6
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versu	6
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates	6
Proceedings of the 17th Annual International INEBRIA Conference	6
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review	6
The associations between public stigma and support for others’ help-seeking for alcohol use disorder: a cross sectional study in the general Danish population	6
Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities	6
Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study	6
“We need all hands on deck”: characterizing addiction medicine training in Canada—a mixed methods study of fellowship program directors	6